查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1592931

失眠治疗药物市场：按类型、分销管道划分 - 全球预测 2025-2030 年

Insomnia Drugs Market by Type (Anti-Parkinsonian Drugs, Anticonvulsants, Antidepressants), Distribution Channels (Online Pharmacies, Retail Pharmacies) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年失眠治疗药物市场规模为29.2亿美元，预计2024年将达30.7亿美元，复合年增长率为5.67%，2030年将达43亿美元。

失眠药物市场包括旨在改善失眠患者睡眠品质和持续时间的药物。失眠的特征是难以入睡和维持睡眠，需要有效的药物治疗，如苯二氮平类、非苯二氮平类安眠药、褪黑激素受体促效剂、Orexin受体拮抗剂等。由于压力、生活方式的改变和人口老化，失眠症越来越普遍，凸显了对市场的需求。失眠治疗药物旨在透过恢復规律的睡眠模式来改善患者的 QOL（生活品质），并被各种最终用户使用，包括医院、诊所和家庭护理机构。关键的成长要素包括心理健康意识的增强以及对先进睡眠障碍治疗的需求。此外，医疗保健支出的增加和药物配方的技术进步也带来了潜在的机会。透过远端医疗平台以及与医疗保健提供者的合作扩大治疗的可近性可以扩大您的市场范围。然而，挑战仍然存在，包括与长期使用相关的副作用、严格的监管核准以及无副作用的替代疗法的出现，例如认知行为疗法。为了解决这些局限性，需要进行研究，重点是开发副作用较少的药物和解决个人化治疗方法的个人化医疗方法。快速药物输送系统和针对调节睡眠的核心途径的药物的创新可能会推动市场成长。投资于非成瘾、天然、永续的睡眠辅助产品的研发可以使公司在这个竞争激烈的市场中脱颖而出。此外，利用穿戴式科技和睡眠监测应用程式等数位健康工具提供了增强患者参与和结果追踪的机会，从而提供有价值的真实世界资料见解。儘管目前面临挑战，但该市场预计将出现显着成长，特别是在开发结合药物治疗和针对患者需求的生活方式介入的协同治疗方面。

主要市场统计
基准年[2023] 29.2亿美元
预测年份 [2024] 30.7亿美元
预测年份 [2030] 43亿美元
复合年增长率（%） 5.67%

市场动态：揭示快速发展的失眠药物市场的关键市场洞察

供需的动态交互作用正在改变失眠药物市场。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 全球失眠盛行率不断上升
    • 提高对失眠各种治疗方案的认识
  • 市场限制因素
    • 与失眠药物相关的副作用
  • 市场机会
    • 持续研究并开发新的失眠疗法
    • 增加失眠中心和睡眠诊断中心
  • 市场挑战
    • 对失眠严重性和患者不遵从治疗的误解

波特五力：驾驭失眠药物市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对失眠治疗市场的影响

外部宏观环境因素在塑造失眠治疗药物市场的表现动态中起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解失眠治疗药物市场竞争状况

对失眠治疗药物市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 失眠治疗药物市场供应商定位矩阵绩效评估

FPNV 定位矩阵是评估失眠治疗药物市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，描绘失眠治疗市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，对失眠治疗药物市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球失眠盛行率增加
      • 提高对失眠不同治疗方法的认识
    • 抑制因素
      • 与失眠药物相关的副作用
    • 机会
      • 新研发失眠治疗药物
      • 增加失眠和睡眠诊断中心
    • 任务
      • 对失眠严重程度和患者不坚持治疗的误解
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章失眠治疗药物市场：依类型

  • 抗帕金森氏症药物
  • 抗惊厥药
  • 抗忧郁症
  • 抗发作性睡病药
  • 苯二氮平类
  • 非苯二氮平类药物
  • Orexin拮抗剂
  • 拉梅尔席恩

第七章按分销管道分類的失眠治疗药物市场

  • 网路药房
  • 零售药房

第八章 北美与南美失眠治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太失眠治疗市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲失眠治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争场景分析
  • 战略分析和建议

公司名单

  • Alembic Pharmaceuticals Limited
  • Astellas Pharma Inc.
  • Aurobindo Pharma Limited
  • Biogen SA
  • Cadila Healthcare Ltd.
  • Dr.Reddy's Laboratories Limited
  • Eisai Co., Ltd.
  • Eli Lilly and Company
  • Flynn Pharma Limited
  • Glenmark Pharmaceuticals Ltd.
  • Idorsia Pharmaceuticals Ltd.
  • LA Herbal（India）
  • Mallinckrodt Pharmaceuticals
  • Merck & Co., Inc.
  • Minerva Neurosciences, Inc.
  • Neuracle Lifesciences Private Limited
  • Neurim Pharmaceuticals LTD.
  • Orexo AB
  • Pfizer Inc.
  • Purdue Pharma LP
  • Sanofi Group
  • Sun Pharmaceutical Industries Limited
  • Takeda Pharmaceutical Company Limited
  • Vanda Pharmaceuticals Inc.
  • Wockhardt Limited
Product Code: MRR-F6513A06BE94

The Insomnia Drugs Market was valued at USD 2.92 billion in 2023, expected to reach USD 3.07 billion in 2024, and is projected to grow at a CAGR of 5.67%, to USD 4.30 billion by 2030.

The insomnia drugs market encompasses pharmaceutical products designed to improve sleep quality and duration in individuals experiencing insomnia. Insomnia, characterized by difficulty in falling or staying asleep, necessitates effective medications like benzodiazepines, non-benzodiazepine hypnotics, melatonin receptor agonists, and orexin receptor antagonists. The growing prevalence of insomnia, driven by stress, lifestyle changes, and an aging population, underscores the market's necessity. It finds application across various end-users, including hospitals, clinics, and homecare settings, aiming to improve patient quality of life by restoring regular sleep patterns. Key growth factors include the increasing awareness of mental health and the need for advanced sleep disorder treatments. Additionally, rising healthcare expenditure and technological advancements in drug formulation present potential opportunities. Expanding the accessibility of treatments through telemedicine platforms and collaborations with healthcare providers can enhance market reach. However, challenges persist in the form of side effects associated with long-term usage, stringent regulatory approvals, and the emergence of side-effect-free alternative therapies like cognitive behavioral therapy. Addressing these limitations involves research focused on developing drugs with reduced adverse effects and personalized medicine approaches for individualized treatment regimens. Innovations in rapid drug delivery systems and drugs targeting core sleep-regulating pathways could advance market growth. Investment in R&D for non-addictive, natural, and sustainable sleep aid products could differentiate companies within this competitive market. Moreover, utilizing digital health tools, such as wearable technology and sleep monitoring apps, offers opportunities to enhance patient engagement and outcome tracking, providing valuable real-world data insights. Despite current challenges, the market holds significant promise for growth, particularly in the development of synergistic therapies, integrating pharmacological treatments with lifestyle interventions tailored to patient needs.

KEY MARKET STATISTICS
Base Year [2023] USD 2.92 billion
Estimated Year [2024] USD 3.07 billion
Forecast Year [2030] USD 4.30 billion
CAGR (%) 5.67%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Insomnia Drugs Market

The Insomnia Drugs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of insomnia across the world
    • Rising awareness about various treatment options available for insomnia
  • Market Restraints
    • Side effects associated with insomnia drugs
  • Market Opportunities
    • Continuous research and development to develop novel insomnia drugs
    • Increase in number of insomnia centers and sleep diagnostic centers
  • Market Challenges
    • Misconceptions about the seriousness of insomnia and patients' non-adherence to the treatment

Porter's Five Forces: A Strategic Tool for Navigating the Insomnia Drugs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Insomnia Drugs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Insomnia Drugs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Insomnia Drugs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Insomnia Drugs Market

A detailed market share analysis in the Insomnia Drugs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Insomnia Drugs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Insomnia Drugs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Insomnia Drugs Market

A strategic analysis of the Insomnia Drugs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Insomnia Drugs Market, highlighting leading vendors and their innovative profiles. These include Alembic Pharmaceuticals Limited, Astellas Pharma Inc., Aurobindo Pharma Limited, Biogen SA, Cadila Healthcare Ltd., Dr.Reddy's Laboratories Limited, Eisai Co., Ltd., Eli Lilly and Company, Flynn Pharma Limited, Glenmark Pharmaceuticals Ltd., Idorsia Pharmaceuticals Ltd., LA Herbal (India), Mallinckrodt Pharmaceuticals, Merck & Co., Inc., Minerva Neurosciences, Inc., Neuracle Lifesciences Private Limited, Neurim Pharmaceuticals LTD., Orexo AB, Pfizer Inc., Purdue Pharma L.P., Sanofi Group, Sun Pharmaceutical Industries Limited, Takeda Pharmaceutical Company Limited, Vanda Pharmaceuticals Inc., and Wockhardt Limited.

Market Segmentation & Coverage

This research report categorizes the Insomnia Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Anti-Parkinsonian Drugs, Anticonvulsants, Antidepressants, Antinarcoleptics, Benzodiazepines, Nonbenzodiazepines, Orexin Antagonist, and Ramelteon.
  • Based on Distribution Channels, market is studied across Online Pharmacies and Retail Pharmacies.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of insomnia across the world
      • 5.1.1.2. Rising awareness about various treatment options available for insomnia
    • 5.1.2. Restraints
      • 5.1.2.1. Side effects associated with insomnia drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Continuous research and development to develop novel insomnia drugs
      • 5.1.3.2. Increase in number of insomnia centers and sleep diagnostic centers
    • 5.1.4. Challenges
      • 5.1.4.1. Misconceptions about the seriousness of insomnia and patients' non-adherence to the treatment
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Insomnia Drugs Market, by Type

  • 6.1. Introduction
  • 6.2. Anti-Parkinsonian Drugs
  • 6.3. Anticonvulsants
  • 6.4. Antidepressants
  • 6.5. Antinarcoleptics
  • 6.6. Benzodiazepines
  • 6.7. Nonbenzodiazepines
  • 6.8. Orexin Antagonist
  • 6.9. Ramelteon

7. Insomnia Drugs Market, by Distribution Channels

  • 7.1. Introduction
  • 7.2. Online Pharmacies
  • 7.3. Retail Pharmacies

8. Americas Insomnia Drugs Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Insomnia Drugs Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Insomnia Drugs Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Alembic Pharmaceuticals Limited
  • 2. Astellas Pharma Inc.
  • 3. Aurobindo Pharma Limited
  • 4. Biogen SA
  • 5. Cadila Healthcare Ltd.
  • 6. Dr.Reddy's Laboratories Limited
  • 7. Eisai Co., Ltd.
  • 8. Eli Lilly and Company
  • 9. Flynn Pharma Limited
  • 10. Glenmark Pharmaceuticals Ltd.
  • 11. Idorsia Pharmaceuticals Ltd.
  • 12. LA Herbal (India)
  • 13. Mallinckrodt Pharmaceuticals
  • 14. Merck & Co., Inc.
  • 15. Minerva Neurosciences, Inc.
  • 16. Neuracle Lifesciences Private Limited
  • 17. Neurim Pharmaceuticals LTD.
  • 18. Orexo AB
  • 19. Pfizer Inc.
  • 20. Purdue Pharma L.P.
  • 21. Sanofi Group
  • 22. Sun Pharmaceutical Industries Limited
  • 23. Takeda Pharmaceutical Company Limited
  • 24. Vanda Pharmaceuticals Inc.
  • 25. Wockhardt Limited

LIST OF FIGURES

  • FIGURE 1. INSOMNIA DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. INSOMNIA DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INSOMNIA DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. INSOMNIA DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. INSOMNIA DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INSOMNIA DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INSOMNIA DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. INSOMNIA DRUGS MARKET DYNAMICS
  • TABLE 7. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ANTI-PARKINSONIAN DRUGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ANTICONVULSANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ANTIDEPRESSANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ANTINARCOLEPTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY BENZODIAZEPINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY NONBENZODIAZEPINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY OREXIN ANTAGONIST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY RAMELTEON, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL INSOMNIA DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 22. ARGENTINA INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 24. BRAZIL INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. BRAZIL INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 26. CANADA INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. CANADA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 28. MEXICO INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. MEXICO INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 32. UNITED STATES INSOMNIA DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 34. ASIA-PACIFIC INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 35. ASIA-PACIFIC INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 36. AUSTRALIA INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. AUSTRALIA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 38. CHINA INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CHINA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 40. INDIA INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. INDIA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 42. INDONESIA INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. INDONESIA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 44. JAPAN INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. JAPAN INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 46. MALAYSIA INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. MALAYSIA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 48. PHILIPPINES INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. PHILIPPINES INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 50. SINGAPORE INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. SINGAPORE INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 52. SOUTH KOREA INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. SOUTH KOREA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 54. TAIWAN INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. TAIWAN INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 56. THAILAND INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. THAILAND INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 58. VIETNAM INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. VIETNAM INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 62. EUROPE, MIDDLE EAST & AFRICA INSOMNIA DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. DENMARK INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. DENMARK INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 65. EGYPT INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. EGYPT INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 67. FINLAND INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. FINLAND INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 69. FRANCE INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. FRANCE INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 71. GERMANY INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. GERMANY INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 73. ISRAEL INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. ISRAEL INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 75. ITALY INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. ITALY INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 77. NETHERLANDS INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. NETHERLANDS INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 79. NIGERIA INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. NIGERIA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 81. NORWAY INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. NORWAY INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 83. POLAND INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. POLAND INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 85. QATAR INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. QATAR INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 87. RUSSIA INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. RUSSIA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 89. SAUDI ARABIA INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SAUDI ARABIA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 91. SOUTH AFRICA INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SOUTH AFRICA INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 93. SPAIN INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SPAIN INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 95. SWEDEN INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. SWEDEN INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 97. SWITZERLAND INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. SWITZERLAND INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 99. TURKEY INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. TURKEY INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED ARAB EMIRATES INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED ARAB EMIRATES INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 103. UNITED KINGDOM INSOMNIA DRUGS MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. UNITED KINGDOM INSOMNIA DRUGS MARKET SIZE, BY DISTRIBUTION CHANNELS, 2018-2030 (USD MILLION)
  • TABLE 105. INSOMNIA DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 106. INSOMNIA DRUGS MARKET, FPNV POSITIONING MATRIX, 2023